U.S. Food and Drug Administration Approves ONGLYZA (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults Thursday, 30 July 2009 22:30 <a href="http://biomedreports.com/articles/new-latest-news/3953-us-food-and-drug-administration-approves-onglyzaq-saxagliptin-for-the-treatment-of-type-2-diabetes-mellitus-in-adults.html" rel="nofollow" target="_blank">http://biomedreports.com/articles/new-latest-news/3953-us-food-and-drug-administration-approves-onglyzaq-saxagliptin-for-the-treatment-of-type-2-diabetes-mellitus-in-adults.html</a>